电话:
+86 (0512) 65829739
传真:
+86 (010) 6788 5057
电子邮件:
orders@antibodies-online.cn

Coronavirus Spike Glycoprotein 蛋白

(Coronavirus Spike Glycoprotein (CoV S))

21 results

CoV S 宿主: SARS Coronavirus-2 (SARS-CoV-2) 宿主: HEK-293 Cells Recombinant > 95 % ELISA Active
产品编号 ABIN7668604
 
CoV S 宿主: SARS Coronavirus-2 (SARS-CoV-2) 宿主: HEK-293 Cells Recombinant > 95 % ELISA Active
产品编号 ABIN7668602
 
CoV S 宿主: SARS Coronavirus-2 (SARS-CoV-2) 宿主: HEK-293 Cells Recombinant > 95 % ELISA Active
产品编号 ABIN7668603
 
CoV S 宿主: SARS Coronavirus-2 (SARS-CoV-2) 宿主: HEK-293 Cells Recombinant > 95 % ELISA Active
产品编号 ABIN7668601
 
CoV S 宿主: SARS Coronavirus-2 (SARS-CoV-2) 宿主: HEK-293 Cells Recombinant > 95 % ELISA Active
产品编号 ABIN7668599
 
CoV S 宿主: SARS Coronavirus-2 (SARS-CoV-2) 宿主: HEK-293 Cells Recombinant > 90 % ELISA Active
产品编号 ABIN7668590
 
CoV S 宿主: SARS Coronavirus-2 (SARS-CoV-2) 宿主: HEK-293 Cells Recombinant > 95 % ELISA Active
产品编号 ABIN7668598
 
CoV S 宿主: SARS Coronavirus-2 (SARS-CoV-2) 宿主: HEK-293 Cells Recombinant > 95 % Inactive
产品编号 ABIN7668594
 
CoV S 宿主: SARS Coronavirus-2 (SARS-CoV-2) 宿主: HEK-293 Cells Recombinant > 95 % Inactive
产品编号 ABIN7668592
 
CoV S 宿主: SARS Coronavirus-2 (SARS-CoV-2) 宿主: HEK-293 Cells Recombinant > 90 % Inactive
产品编号 ABIN7668596
 
CoV S 宿主: SARS Coronavirus-2 (SARS-CoV-2) 宿主: HEK-293 Cells Recombinant > 95 % Inactive
产品编号 ABIN7668595
 
CoV S 宿主: SARS Coronavirus-2 (SARS-CoV-2) 宿主: HEK-293 Cells Recombinant > 95 % ELISA Active
产品编号 ABIN7668597
 
CoV S 宿主: SARS Coronavirus-2 (SARS-CoV-2) 宿主: HEK-293 Cells Recombinant > 95 % ELISA Active
产品编号 ABIN7668600
 
CoV S 宿主: SARS Coronavirus-2 (SARS-CoV-2) 宿主: HEK-293 Cells Recombinant > 95 % BLI Active
产品编号 ABIN7668593
 
CoV S 宿主: SARS Coronavirus (SARS-CoV) 宿主: HEK-293 Cells Recombinant > 95 % ELISA Active
产品编号 ABIN7668589
 
CoV S 宿主: SARS Coronavirus-2 (SARS-CoV-2) 宿主: HEK-293 Cells Recombinant > 95 % BLI Active
产品编号 ABIN7668588
 
CoV S 宿主: SARS Coronavirus-2 (SARS-CoV-2) 宿主: HEK-293 Cells Recombinant > 95 % ELISA Active
产品编号 ABIN7668591
 
CoV S 宿主: Human Coronavirus NL63 (HCoV-NL63) 宿主: HEK-293 Cells Recombinant >90 % as determined by SDS-PAGE.
产品编号 ABIN7013040
 
CoV S 宿主: Human Coronavirus HKU1 (HCoV-HKU1) 宿主: HEK-293 Cells Recombinant >95 % as determined by reduced SDS-PAGE.
产品编号 ABIN7013038
 
CoV S 宿主: Human Coronavirus 229E (HCoV-229E) 宿主: HEK-293 Cells Recombinant >90 % as determined by SDS-PAGE.
产品编号 ABIN7013036
 
  • 类型 Protein
    • Protein
  • 应用范围
    • ELISA
    • Bio-Layer Interferometry (BLI)
  • 适用
    • SARS Coronavirus-2 (SARS-CoV-2)
    • Human Coronavirus HKU1 (HCoV-HKU1)
    • Human Coronavirus 229E (HCoV-229E)
    • Human Coronavirus NL63 (HCoV-NL63)
    • SARS Coronavirus (SARS-CoV)
  • Carrier free only
  • 抗体来源
    • HEK-293 Cells
  • 抗原表位
    • Receptor Binding Domain
    • AA 14-685
    • AA 13-1276
    • AA 15-1208
    • AA 319-591
    • AA 331-524
    • AA 14-1190
    • AA 14-290
    • AA 16-1115
    • AA 16-1291
    • AA 16-685
    • AA 319-541
    • AA 319-589
    • AA 686-1208
    • N-Term
  • 标记
    • His tag
    • mFc Tag
    • Fc Tag
    • Biotin,His-Avi Tag
    • His tag,AVI tag,Biotin
    • His-DYKDDDDK Tag
    • mFc-His Tag
    • 非结合性
  • 蛋白类型
    • Recombinant
  • Format
    • Liquid
    • Lyophilized
  • 生物活性
    • Biologically Active
    • Biologically Inactive
  • Supplier
    • antibodies-online
    • ACROBiosystems

Latest Publications for our Coronavirus Spike Glycoprotein 蛋白

Longworth, Dittmar: "An antigen microarray protocol for COVID-19 serological analysis." in: STAR protocols, Vol. 2, Issue 3, pp. 100815, (2021) (PubMed).

Johnson, Drugan, Miller, Evans: "38" in: , Vol. 1363, Issue Nucleic acids research, pp. 28-39, (1991)

Al Kahlout, Nasrallah, Farag, Wang, Lattwein, Müller, El Zowalaty, Al Romaihi, Graham, Al Thani, Yassine: "Comparative Serological Study for the Prevalence of Anti-MERS Coronavirus Antibodies in High- and Low-Risk Groups in Qatar." in: Journal of immunology research, Vol. 2019, pp. 1386740, (2019) (PubMed).

Aliases for Coronavirus Spike Glycoprotein 蛋白

E2 glycoprotein precursor (S) 蛋白
E2 蛋白
You are here:
Chat with us!